Beam Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $490 | $31,738 | $114,109 | $9,698 |
Gross Profit | 490 | 20,682 | 108,441 | -100,071 |
EBITDA | -125,018 | -88,713 | 260,605 | -107,168 |
EBIT | -130,428 | -94,318 | 254,937 | -112,728 |
Net Income | -122,678 | -94,318 | 244,297 | -112,728 |
Net Change In Cash | 490 | 31,738 | 114,109 | 9,698 |
Free Cash Flow | -68,510 | -130,745 | -87,023 | -86,490 |
Cash | 219,825 | 288,291 | 294,944 | 267,959 |
Basic Shares | 104,326 | 103,262 | 104,927 | 102,570 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $139,743 | $63,518 | $377,709 | $60,920 |
Gross Profit | 117,449 | -304,043 | 377,709 | -250,674 |
EBITDA | -29,923 | -354,778 | -101,630 | -271,531 |
EBIT | -36,259 | -376,703 | -131,161 | -285,678 |
Net Income | -79,992 | -376,742 | -132,527 | -289,088 |
Net Change In Cash | 139,743 | 63,518 | 377,709 | 60,920 |
Free Cash Flow | -360,048 | -356,192 | -182,927 | -26,424 |
Cash | 294,944 | 281,967 | 435,895 | 232,767 |
Basic Shares | 98,905 | 82,313 | 77,151 | 70,015 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.18 |
2026-03-31 | -$0.91 |
2025-12-31 | $2.33 |
2025-09-30 | -$1.10 |